The difference between Lorlatinib and Lorlatinib
Lorlatinib (Lorlatinib) and lorlatinib are the same drug, but they are transliterated differently in different contexts. This is the case because drugs often have international nonproprietary names (INN) on the international market, and different countries and regions translate and transliterate them according to their language and phonetic rules to better communicate with local medical professionals and patients.
Lorlatinib is a highly targeted anticancer drug that belongs to a class of tyrosine kinase inhibitors. Its main role is to target patients with non-small cell lung cancer (NSCLC) with fusion gene mutations of ALK (tyrosine kinase) and ROS1 (ROS1kinase). Mutations in these genes are major drivers of lung cancer cell growth and spread.

Lorlatinib is unique in that it not only targets ALK and ROS1, but also has multiple targeting properties, which can cope with the emergence of some drug-resistant mutations. Therefore, lorlatinib provides a new treatment option for patients who have previously developed resistance to other ALK inhibitors.
This drug has shown significant efficacy in a series of clinical trials, enabling many patients with ALK and ROS1-positive NSCLC to achieve longer progression-free survival and better quality of life.
Overall, lorlatinib represents an important advance in the field of lung cancer treatment. As a targeted therapy, it provides new treatment hope for lung cancer patients with specific gene mutations. Regardless of the transliteration, this drug represents the continued development and advancement of medical science and cancer treatment.
Lorlatinib has been launched in China and is included in medical insurance. Patients can purchase it domestically, but the price is relatively high, about 10,000 to 20,000 yuan. For details, please consult the local hospital pharmacy. There are original drugs and cheaper generic drugs abroad. The cheaper ones are the original drugs from Turkey, which cost more than 1,000 yuan, and the original drugs from Hong Kong, China, which cost about 30,000 yuan. Generic drugs are mainly generic drugs from Laos and Bangladesh. The price is about several thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)